rgn-137
Generic: Thymosin beta 4
rgn-137: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| REGENERX BIOPHARMACEUTICALS INC (RGRX) | Phase 3 |
Get deeper analysis on rgn-137
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis